← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Geovax, Inc.
Smyrna, GA
$29,374,629
Total funding
16
Grants
Funding over time
peak $9.8M · FY2007–21$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$26,932,322 · 15
DOD$2,442,307 · 1
By mechanism
U19$20,915,564 · 5
—$2,442,307 · 1
R43$2,159,881 · 5
U01$1,859,000 · 1
R44$1,698,435 · 2
N01$199,442 · 1
Investigators at Geovax, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines$4,885,098
U19 · FY2010 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines$4,736,301
U19 · FY2009 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines$4,352,253
U19 · FY2011 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines$3,478,707
U19 · FY2008 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines$2,915,139
U19 · FY2007 · AI
ADVANCED PRECLINICAL DEVELOPMENT AND PRODUCTION OF MASTER SEE VIRUS OF GEO-LM01, A NOVEL MVA-VLP VACCINE AGAINST LASSA FEVER$2,442,307
· FY2018 · Defense Health Agency
Product Development and Manufacture$2,111,768
U19 · FY2011 · AI
Product Development and Manufacture$2,045,526
U19 · FY2010 · AI
Product Development and Manufacture$1,982,812
U19 · FY2009 · AI
Project 1: Immunogens and Manufacturing$1,859,000
U01 · FY2012 · AI
Preclinical Studies and Mucosal Responses$1,386,249
U19 · FY2011 · AI
Preclinical Studies and Mucosal Responses$1,283,173
U19 · FY2010 · AI
Preclinical Studies and Mucosal Responses$1,244,087
U19 · FY2009 · AI
Product Development and Manufacture$1,229,292
U19 · FY2008 · AI
Product Development and Manufacture$1,203,014
U19 · FY2007 · AI
Clinical Trials and Ancillary Assays$874,348
U19 · FY2011 · AI
Preclinical Studies and Mucosal Responses$771,455
U19 · FY2008 · AI
Preclinical Studies and Mucosal Responses$754,406
U19 · FY2007 · AI
Clinical Trials and Ancillary Assays$745,000
U19 · FY2010 · AI
Enhancing protective antibody responses for a DNA/MVA HIV vaccine$740,456
R44 · FY2016 · AI